WORLDREMIT
4.2.2021 02:56:08 CET | Business Wire | Press release
WorldRemit, a leading digital cross-border payments business has announced the winners of its recent Grainsmart store franchise promotion to help customers give their beneficiaries the opportunity to start a business in the Philippines. Customers qualified for the promotion by sending money to the Philippines and nominating a beneficiary of their choice. The winners include frontline healthcare workers and teachers from a number of countries including the United Kingdom, Norway, Australia, Canada, New Zealand, Sweden and the United States. Beneficiaries will now be opening Grainsmart stores across the Philippines in places which include Cebu, Davao, San Carlos and Tagum City.
“We’re so pleased to give recipients this great opportunity to start a business that will help them to support their families and become more financially stable. The franchisees have the option to expand these businesses and potentially create job opportunities for members of the wider community. This underlines our commitment to helping Overseas Filipino Workers to support those dearest to them back home,” said Earl Melivo, Country Director for the Philippines at WorldRemit.
Benjamin Batac, CEO at Grainsmart added, “It’s an honour to partner with a company like WorldRemit that shares our values. With many of the franchise contracts already signed, this promotion will create sustainable jobs and also give much-needed support to Filipino farmers, many of whom are facing challenges due to the pandemic and recent natural disasters”.
Winner Emilie Ann Estavas who works as a healthcare assistant in a care home in Oxfordshire said, “I’m very happy and excited with the prize and so grateful to WorldRemit and Grainsmart. It is really a surprise. The Pangkabuhayan package will help my family back in the Philippines to start a business which is a huge blessing and a big help. It is a great opportunity and I’m planning to expand the business while we are here still working abroad. I am hoping and praying that God will bless the business and make it prosper so that in the near future it will help us to retire early, go home and continue running the business with my family. Fingers crossed!”.
Winner and frontline worker Melissa Zibas has chosen her cousin Adan who lives in San Carlos City, Pangasinan as her beneficiary. She said, “Adan is a former seafarer and is pretty adventurous like me so I know he’ll make a huge success of the Grainsmart business. We’re a very close family so I hope we can grow the business and include other members of our family. The covid-19 pandemic has really tested everyone's lives so it's great to start a business that will be needed by people as rice is our staple food”.
Rosa Mae who lives in Norway and is studying to become a youth worker, chose her sister Rhea as her beneficiary. Rhea who lives and works in Tagum City as a doctor’s secretary said, “I’m so grateful to my big sister for giving me this opportunity. I miss her so much now that she lives over 10,000 miles away in Oslo. Sending transfers through WorldRemit is her way of supporting and staying connected to us and now it has given me the chance to start my own business. We grew up in Davao de Oro and our parents still live there so I’m looking forward to running the Grainsmart franchise with them”.
Each Grainsmart franchise business package includes:
- 60 sacks (25 kg each) of rice
- A tablet that’s fully set up for a bills payment center account
- Business signage, marketing collateral, and other business paraphernalia
- An online training and mentorship program – to provide guidance for setting up the business for success
As well as the COVID-19 pandemic, Filipinos have also had to deal with the devastation caused by Super Typhoon Goni and Typhoon Vamco, which have displaced thousands and destroyed livelihoods.
Take advantage of competitive exchange rates for the Philippine peso by visiting www.worldremit.com or downloading the app.
Winners were announced on the WorldRemit Facebook page (https://www.facebook.com/WorldRemit/ ).
For more details visit www.worldremit.com/pangkabuhayan .
WorldRemit
WorldRemit is a leading digital cross-border payments business. We disrupted an industry previously dominated by offline legacy players by taking international money transfers online - making them safer, faster and lower-cost. We currently send from more than 50 countries to 130+ receive countries, operate in 6,500 money transfer corridors worldwide and employ over 1,100 people worldwide.
On the sending side WorldRemit is 100% digital (cashless), increasing convenience and enhancing security. For those receiving money, the company offers a wide range of options including bank deposit, cash collection, mobile airtime top-up and mobile money.
Backed by Accel, TCV and Leapfrog – WorldRemit’s headquarters are in London, United Kingdom with regional offices in the United States, Canada, Australia, New Zealand, Hong Kong, Singapore, Malaysia, the Philippines, South Africa, Somaliland, Uganda, Kenya, Rwanda, Tanzania, Zimbabwe and Belgium.
For more information visit www.worldremit.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210203006021/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom